• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by Translational Development Acquisition Corp.

    5/13/26 10:53:17 AM ET
    $TDAC
    Get the next $TDAC alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.

    (Name of Issuer)


    Class A ordinary shares, $0.0001 par value per share

    (Title of Class of Securities)




    G9008W105

    (CUSIP Number)
    03/31/2026

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)




    schemaVersion:


    SCHEDULE 13G

    CUSIP Number(s):
    G9008W105


    1Names of Reporting Persons

    THE GOLDMAN SACHS GROUP, INC.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,054,120.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,054,120.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,054,120.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    6.1 %
    12Type of Reporting Person (See Instructions)

    HC, CO


    SCHEDULE 13G

    CUSIP Number(s):
    G9008W105


    1Names of Reporting Persons

    GOLDMAN SACHS & CO. LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    NEW YORK
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    1,054,120.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    1,054,120.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,054,120.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    6.1 %
    12Type of Reporting Person (See Instructions)

    BD, OO, IA


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    TRANSLATIONAL DEVELOPMENT ACQUISITION CORP.
    (b)Address of issuer's principal executive offices:

    52 E. 83rd Street, New York, X1, 10028
    Item 2. 
    (a)Name of person filing:

    THE GOLDMAN SACHS GROUP, INC.| GOLDMAN SACHS & CO. LLC
    (b)Address or principal business office or, if none, residence:

    The Goldman Sachs Group, Inc. 200 West Street New York, NY 10282| Goldman Sachs & Co. LLC 200 West Street New York, NY 10282
    (c)Citizenship:

    THE GOLDMAN SACHS GROUP, INC. - Delaware| GOLDMAN SACHS & CO. LLC - New York
    (d)Title of class of securities:

    Class A ordinary shares, $0.0001 par value per share
    (e)CUSIP Number(s):

    G9008W105
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    See the response(s) to Item 9 on the attached cover page(s).
    (b)Percent of class:

    See the response(s)to Item 11 on the attached cover page(s).
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    See the response(s) to Item 5 on the attached cover page(s).

     (ii) Shared power to vote or to direct the vote:

    See the response(s) to Item 6 on the attached cover page(s).

     (iii) Sole power to dispose or to direct the disposition of:

    See the response(s) to Item 7 on the attached cover page(s).

     (iv) Shared power to dispose or to direct the disposition of:

    See the response(s) to Item 8 on the attached cover page(s).

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    See Exhibit (99.2)
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    THE GOLDMAN SACHS GROUP, INC.
     
    Signature:Name: Veronica Mupazviriwo
    Name/Title:Attorney-in-fact
    Date:05/07/2026
     
    GOLDMAN SACHS & CO. LLC
     
    Signature:Name: Veronica Mupazviriwo
    Name/Title:Attorney-in-fact
    Date:05/07/2026
    Exhibit Information

    EXHIBIT (99.1) JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Class A ordinary shares, $0.0001 par value per share, of TRANSLATIONAL DEVELOPMENT ACQUISITION CORP. and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G. Date: 05/07/2026 THE GOLDMAN SACHS GROUP, INC. By:/s/ Veronica Mupazviriwo ---------------------------------------- Name: Veronica Mupazviriwo Title: Attorney-in-fact GOLDMAN SACHS & CO. LLC By:/s/ Veronica Mupazviriwo ---------------------------------------- Name: Veronica Mupazviriwo Title: Attorney-in-fact EXHIBIT (99.2) ITEM 7 INFORMATION The securities being reported on by The Goldman Sachs Group, Inc. ("GS Group"), as a parent holding company, are owned, or may be deemed to be beneficially owned, by Goldman Sachs & Co. LLC ("Goldman Sachs"), a broker or dealer registered under Section 15 of the Act and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940. Goldman Sachs is a subsidiary of GS Group. EXHIBIT (99.3) ITEM 4 INFORMATION *In accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned by certain operating units (collectively, the "Goldman Sachs Reporting Units") of The Goldman Sachs Group, Inc. and its subsidiaries and affiliates (collectively, "GSG"). This filing does not reflect securities, if any, beneficially owned by any operating units of GSG whose ownership of securities is disaggregated from that of the Goldman Sachs Reporting Units in accordance with the Release. The Goldman Sachs Reporting Units disclaim beneficial ownership of the securities beneficially owned by (i) any client accounts with respect to which the Goldman Sachs Reporting Units or their employees have voting or investment discretion or both, or with respect to which there are limits on their voting or investment authority or both and (ii) certain investment entities of which the Goldman Sachs Reporting Units act as the general partner, managing general partner or other manager, to the extent interests in such entities are held by persons other than the Goldman Sachs Reporting Units.

    Get the next $TDAC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TDAC

    DatePrice TargetRatingAnalyst
    9/21/2021$16.00Outperform
    Northland Capital Markets
    More analyst ratings

    $TDAC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital Markets initiated coverage on Trident Acquisitions with a new price target

    Northland Capital Markets initiated coverage of Trident Acquisitions with a rating of Outperform and set a new price target of $16.00

    9/21/21 8:09:12 AM ET
    $TDAC

    $TDAC
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Translational Development Acquisition Corp.

    SCHEDULE 13G - Translational Development Acquisition Corp. (0001926599) (Subject)

    6/2/26 2:23:29 PM ET
    $TDAC

    SEC Form DEFA14A filed by Translational Development Acquisition Corp.

    DEFA14A - Translational Development Acquisition Corp. (0001926599) (Filer)

    5/28/26 5:21:02 PM ET
    $TDAC

    SEC Form DEF 14A filed by Translational Development Acquisition Corp.

    DEF 14A - Translational Development Acquisition Corp. (0001926599) (Filer)

    5/27/26 5:07:50 PM ET
    $TDAC

    $TDAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chairman and CEO Hoffman Michael B

    4 - Translational Development Acquisition Corp. (0001926599) (Issuer)

    5/29/26 4:05:16 PM ET
    $TDAC

    SEC Form 3 filed by new insider Jarratt Christopher Kenneth

    3 - Translational Development Acquisition Corp. (0001926599) (Issuer)

    1/6/25 4:05:09 PM ET
    $TDAC

    SEC Form 3 filed by new insider Keith Curtis T

    3 - Translational Development Acquisition Corp. (0001926599) (Issuer)

    12/20/24 6:59:32 PM ET
    $TDAC

    $TDAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ProLogium, a Next Generation Solid-State Battery Developer with 10+ Years of Proven Commercialization, to List on the Nasdaq through a Merger with Translational Development Acquisition Corp.

    ProLogium reached commercial-scale manufacturing for solid-state batteries in 2013, later delivered the world's first solid-state battery demo car with ENOVATE Motor in 2019. ProLogium has shipped a total of over 2.4 million battery cells to customers since 2013, of which more than 800,000 are its 3rd-generation batteries from the Gigafactory in Taiwan. With a portfolio of 1,100+ patents, ProLogium has introduced its 4th-generation superfluidized inorganic solid-state battery solution with zero thermal runaway, high energy density, low temperature performance, fast charging, competitive cost, and commercial readiness. Pre-money valuation of ProLogium is expected to be approximately $3.8 bill

    5/27/26 7:00:00 AM ET
    $TDAC

    Lottery.com to Present at the 10th Annual Gateway Conference on September 9, 2021

    AUSTIN, TX / ACCESSWIRE / September 2, 2021 / AutoLotto, Inc. ("Lottery.com"), a leading technology company that is transforming how, where and when the lottery is played, announced today that its management will participate in the virtual 10th Annual Gateway ConferenceLottery.com's management is scheduled to present on Thursday, September 9th at 8:00 a.m. Pacific time, with one-on-one meetings to be held throughout the day. The presentation will be webcast live and available for replay here.To receive additional information, request an invitation, or schedule a one-on-one meeting, please email conference@gatewayir.com.On Feb. 21, 2021, Lottery.com entered into a definitive agreement with Tr

    9/2/21 4:15:00 PM ET
    $TDAC

    10th Annual Gateway Conference to Virtually Showcase Leading Companies on September 8-9, 2021

    Executives from a Range of Industries to Present to 500+ Investors and AnalystsNEWPORT BEACH, CA / ACCESSWIRE / August 24, 2021 / The Gateway Conference is back for its 10th year and will showcase leading public and private companies virtually on September 8th and 9th.Attendees will have the opportunity to discover and learn about a select group of compelling companies across a wide range of industries, including consumer & wellness, financials, internet & business services, industrials, technology & electric vehicles, and SPACs.The invitation-only conference provides investors and analysts a unique opportunity to gain valuable insights during two days of presentations and one-on-one meeting

    8/24/21 1:30:00 PM ET
    $AROC
    $AUTO
    $AWRE
    Natural Gas Distribution
    Utilities
    Business Services
    Consumer Discretionary

    $TDAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed

    SC 13G - Trident Acquisitions Corp. (0001673481) (Subject)

    2/12/21 4:30:21 PM ET
    $TDAC